Growth and Tolerance Assessment of a Lutein-fortified Infant Formula

Purpose: To evaluate safety, gastrointestinal tolerance, and growth of a new experimental starter formula (NESF) fortified with lutein, prebiotics, probiotics, nucleotides and beta-carotene, fed to infants within the first months of life. Methods: This was a non-randomized, open, uncontrolled study...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Pediatric gastroenterology, hepatology & nutrition hepatology & nutrition, 2014, Vol.17 (2), p.104-111
Hauptverfasser: Kon, Igor Ya, Gmoshinskaya, Maria V, Safronova, Adilya I, Alarcon, Pedro, Vandenplas, Yvan
Format: Artikel
Sprache:kor
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 111
container_issue 2
container_start_page 104
container_title Pediatric gastroenterology, hepatology & nutrition
container_volume 17
creator Kon, Igor Ya
Gmoshinskaya, Maria V
Safronova, Adilya I
Alarcon, Pedro
Vandenplas, Yvan
description Purpose: To evaluate safety, gastrointestinal tolerance, and growth of a new experimental starter formula (NESF) fortified with lutein, prebiotics, probiotics, nucleotides and beta-carotene, fed to infants within the first months of life. Methods: This was a non-randomized, open, uncontrolled study conducted from December 2010 to May 2011. Twenty-three healthy infants aged 10 days to 2 months old were enrolled. Outcomes included gastrointestinal tolerance, physical growth and safety. Prior to the initiation of the trial, the Scientific Research Institute of Nutrition of the Russian Academy of Medical Sciences confirmed that the NESF met all safety and nutritional parameters. Results: NESF was well tolerated. The majority of infants fed this formula passed semi-liquid, yellow or yellow-brown. The mean stool frequency/day was $2.5{\pm}0.4$ on study-day 14 and $1.8{\pm}0.5$ on study-day 28. The mean daily weight gain was $30.9{\pm}3.8$ grams and the mean length gain during the 28 days of follow up was $3.1{\pm}0.8cm$, corresponding to the average physical growth normally seen in the first months of life in Russian infants. Six children left the study: one refused to drink the formula, one left the study as parents changed residence; and one child's parents have recalled their informed consent due to adverse event unrelated to the product. Three infants presented adverse events possibly related to the product (rash; colic and abdominal pain; constipation). Seventeen infants completed the trial. Conclusion: This study demonstrated that lutein-fortified formula is safe, well-tolerated and supported physical growth of evaluated infants.
format Article
fullrecord <record><control><sourceid>kisti</sourceid><recordid>TN_cdi_kisti_ndsl_JAKO201424566495525</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>JAKO201424566495525</sourcerecordid><originalsourceid>FETCH-kisti_ndsl_JAKO2014245664955253</originalsourceid><addsrcrecordid>eNqNir0KwjAYAIMoWLTvkMWxEPNnHYtaf8Gle4k2wWCaQL4UX18H3Z3u4G6EMkoZL8qSk_HPJZdTlAPYG2ElWUnKSYa2-xhe6YGV73ATnI7K3zWuADRAr33CwWCFL0PS1hcmxGSN1R0-eqM-sQ6xH5yao4lRDnT-5Qwt6l2zORRPC8m2vgPXnqrzlZIlp1xIyddCUMH-_d42ZzqC</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Growth and Tolerance Assessment of a Lutein-fortified Infant Formula</title><source>KoreaMed Synapse</source><source>PMC (PubMed Central)</source><source>PubMed Central Open Access</source><source>KoreaMed Open Access</source><source>EZB-FREE-00999 freely available EZB journals</source><creator>Kon, Igor Ya ; Gmoshinskaya, Maria V ; Safronova, Adilya I ; Alarcon, Pedro ; Vandenplas, Yvan</creator><creatorcontrib>Kon, Igor Ya ; Gmoshinskaya, Maria V ; Safronova, Adilya I ; Alarcon, Pedro ; Vandenplas, Yvan</creatorcontrib><description>Purpose: To evaluate safety, gastrointestinal tolerance, and growth of a new experimental starter formula (NESF) fortified with lutein, prebiotics, probiotics, nucleotides and beta-carotene, fed to infants within the first months of life. Methods: This was a non-randomized, open, uncontrolled study conducted from December 2010 to May 2011. Twenty-three healthy infants aged 10 days to 2 months old were enrolled. Outcomes included gastrointestinal tolerance, physical growth and safety. Prior to the initiation of the trial, the Scientific Research Institute of Nutrition of the Russian Academy of Medical Sciences confirmed that the NESF met all safety and nutritional parameters. Results: NESF was well tolerated. The majority of infants fed this formula passed semi-liquid, yellow or yellow-brown. The mean stool frequency/day was $2.5{\pm}0.4$ on study-day 14 and $1.8{\pm}0.5$ on study-day 28. The mean daily weight gain was $30.9{\pm}3.8$ grams and the mean length gain during the 28 days of follow up was $3.1{\pm}0.8cm$, corresponding to the average physical growth normally seen in the first months of life in Russian infants. Six children left the study: one refused to drink the formula, one left the study as parents changed residence; and one child's parents have recalled their informed consent due to adverse event unrelated to the product. Three infants presented adverse events possibly related to the product (rash; colic and abdominal pain; constipation). Seventeen infants completed the trial. Conclusion: This study demonstrated that lutein-fortified formula is safe, well-tolerated and supported physical growth of evaluated infants.</description><identifier>ISSN: 2234-8646</identifier><identifier>EISSN: 2234-8840</identifier><language>kor</language><ispartof>Pediatric gastroenterology, hepatology &amp; nutrition, 2014, Vol.17 (2), p.104-111</ispartof><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>230,314,780,784,885,4024</link.rule.ids></links><search><creatorcontrib>Kon, Igor Ya</creatorcontrib><creatorcontrib>Gmoshinskaya, Maria V</creatorcontrib><creatorcontrib>Safronova, Adilya I</creatorcontrib><creatorcontrib>Alarcon, Pedro</creatorcontrib><creatorcontrib>Vandenplas, Yvan</creatorcontrib><title>Growth and Tolerance Assessment of a Lutein-fortified Infant Formula</title><title>Pediatric gastroenterology, hepatology &amp; nutrition</title><addtitle>Pediatric gastroenterology, hepatology &amp; nutrition</addtitle><description>Purpose: To evaluate safety, gastrointestinal tolerance, and growth of a new experimental starter formula (NESF) fortified with lutein, prebiotics, probiotics, nucleotides and beta-carotene, fed to infants within the first months of life. Methods: This was a non-randomized, open, uncontrolled study conducted from December 2010 to May 2011. Twenty-three healthy infants aged 10 days to 2 months old were enrolled. Outcomes included gastrointestinal tolerance, physical growth and safety. Prior to the initiation of the trial, the Scientific Research Institute of Nutrition of the Russian Academy of Medical Sciences confirmed that the NESF met all safety and nutritional parameters. Results: NESF was well tolerated. The majority of infants fed this formula passed semi-liquid, yellow or yellow-brown. The mean stool frequency/day was $2.5{\pm}0.4$ on study-day 14 and $1.8{\pm}0.5$ on study-day 28. The mean daily weight gain was $30.9{\pm}3.8$ grams and the mean length gain during the 28 days of follow up was $3.1{\pm}0.8cm$, corresponding to the average physical growth normally seen in the first months of life in Russian infants. Six children left the study: one refused to drink the formula, one left the study as parents changed residence; and one child's parents have recalled their informed consent due to adverse event unrelated to the product. Three infants presented adverse events possibly related to the product (rash; colic and abdominal pain; constipation). Seventeen infants completed the trial. Conclusion: This study demonstrated that lutein-fortified formula is safe, well-tolerated and supported physical growth of evaluated infants.</description><issn>2234-8646</issn><issn>2234-8840</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2014</creationdate><recordtype>article</recordtype><sourceid>JDI</sourceid><recordid>eNqNir0KwjAYAIMoWLTvkMWxEPNnHYtaf8Gle4k2wWCaQL4UX18H3Z3u4G6EMkoZL8qSk_HPJZdTlAPYG2ElWUnKSYa2-xhe6YGV73ATnI7K3zWuADRAr33CwWCFL0PS1hcmxGSN1R0-eqM-sQ6xH5yao4lRDnT-5Qwt6l2zORRPC8m2vgPXnqrzlZIlp1xIyddCUMH-_d42ZzqC</recordid><startdate>2014</startdate><enddate>2014</enddate><creator>Kon, Igor Ya</creator><creator>Gmoshinskaya, Maria V</creator><creator>Safronova, Adilya I</creator><creator>Alarcon, Pedro</creator><creator>Vandenplas, Yvan</creator><scope>JDI</scope></search><sort><creationdate>2014</creationdate><title>Growth and Tolerance Assessment of a Lutein-fortified Infant Formula</title><author>Kon, Igor Ya ; Gmoshinskaya, Maria V ; Safronova, Adilya I ; Alarcon, Pedro ; Vandenplas, Yvan</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-kisti_ndsl_JAKO2014245664955253</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>kor</language><creationdate>2014</creationdate><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Kon, Igor Ya</creatorcontrib><creatorcontrib>Gmoshinskaya, Maria V</creatorcontrib><creatorcontrib>Safronova, Adilya I</creatorcontrib><creatorcontrib>Alarcon, Pedro</creatorcontrib><creatorcontrib>Vandenplas, Yvan</creatorcontrib><collection>KoreaScience</collection><jtitle>Pediatric gastroenterology, hepatology &amp; nutrition</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Kon, Igor Ya</au><au>Gmoshinskaya, Maria V</au><au>Safronova, Adilya I</au><au>Alarcon, Pedro</au><au>Vandenplas, Yvan</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Growth and Tolerance Assessment of a Lutein-fortified Infant Formula</atitle><jtitle>Pediatric gastroenterology, hepatology &amp; nutrition</jtitle><addtitle>Pediatric gastroenterology, hepatology &amp; nutrition</addtitle><date>2014</date><risdate>2014</risdate><volume>17</volume><issue>2</issue><spage>104</spage><epage>111</epage><pages>104-111</pages><issn>2234-8646</issn><eissn>2234-8840</eissn><abstract>Purpose: To evaluate safety, gastrointestinal tolerance, and growth of a new experimental starter formula (NESF) fortified with lutein, prebiotics, probiotics, nucleotides and beta-carotene, fed to infants within the first months of life. Methods: This was a non-randomized, open, uncontrolled study conducted from December 2010 to May 2011. Twenty-three healthy infants aged 10 days to 2 months old were enrolled. Outcomes included gastrointestinal tolerance, physical growth and safety. Prior to the initiation of the trial, the Scientific Research Institute of Nutrition of the Russian Academy of Medical Sciences confirmed that the NESF met all safety and nutritional parameters. Results: NESF was well tolerated. The majority of infants fed this formula passed semi-liquid, yellow or yellow-brown. The mean stool frequency/day was $2.5{\pm}0.4$ on study-day 14 and $1.8{\pm}0.5$ on study-day 28. The mean daily weight gain was $30.9{\pm}3.8$ grams and the mean length gain during the 28 days of follow up was $3.1{\pm}0.8cm$, corresponding to the average physical growth normally seen in the first months of life in Russian infants. Six children left the study: one refused to drink the formula, one left the study as parents changed residence; and one child's parents have recalled their informed consent due to adverse event unrelated to the product. Three infants presented adverse events possibly related to the product (rash; colic and abdominal pain; constipation). Seventeen infants completed the trial. Conclusion: This study demonstrated that lutein-fortified formula is safe, well-tolerated and supported physical growth of evaluated infants.</abstract><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 2234-8646
ispartof Pediatric gastroenterology, hepatology & nutrition, 2014, Vol.17 (2), p.104-111
issn 2234-8646
2234-8840
language kor
recordid cdi_kisti_ndsl_JAKO201424566495525
source KoreaMed Synapse; PMC (PubMed Central); PubMed Central Open Access; KoreaMed Open Access; EZB-FREE-00999 freely available EZB journals
title Growth and Tolerance Assessment of a Lutein-fortified Infant Formula
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-25T04%3A16%3A27IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-kisti&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Growth%20and%20Tolerance%20Assessment%20of%20a%20Lutein-fortified%20Infant%20Formula&rft.jtitle=Pediatric%20gastroenterology,%20hepatology%20&%20nutrition&rft.au=Kon,%20Igor%20Ya&rft.date=2014&rft.volume=17&rft.issue=2&rft.spage=104&rft.epage=111&rft.pages=104-111&rft.issn=2234-8646&rft.eissn=2234-8840&rft_id=info:doi/&rft_dat=%3Ckisti%3EJAKO201424566495525%3C/kisti%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true